Patterns of adherence to antiretroviral medications: the value of electronic monitoring

被引:40
作者
McNabb, JJ
Nicolau, DP
Stoner, JA
Ross, J
机构
[1] Univ Nebraska, Med Ctr, Coll Pharm, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Coll Med, Omaha, NE 68198 USA
[3] Hartford Hosp, Res Off, Hartford, CT 06102 USA
[4] Hartford Hosp, Div Infect Dis, Hartford, CT 06102 USA
关键词
adherence; antiretroviral therapy; drug users; electronic monitoring; outcome;
D O I
10.1097/00002030-200308150-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To investigate the patterns of intra-subject (between medication) adherence to antiretroviral therapy. Design: A prospective, observational, 3-month study of adherence to antiretroviral therapy at an inner-city clinic in 40 HIV-infected subjects. Methods: Adherence was monitored monthly by the use of medication event monitoring system (Aprex) caps placed on each antiretroviral drug in a subject's regimen. Agreement between different drug classes and dosing schedules, for each subject, was quantified by estimating the mean difference in adherence, with 95% limits of agreement. An analysis of variance model was used to estimate the variance of the differences. individual dosing calendars were examined for each subject. Results: The dosing schedule was a strong predictor of intra-subject adherence. Regardless of the subject's overall adherence rate, high or low, when subjects missed a dose of one medication, they missed a dose of both medications taken at that dosing time. Conversely, when medications were scheduled to be taken together, regardless of the drug class, the medications were taken at the same times. The majority of the subjects took medications at obviously incorrect times. Problematical adherence was related to thrice-daily dosing and food restrictions. Conclusion: This is the first report objectively to quantify intra-subject adherence to antiretroviral therapy and report the findings in detail. We observed clear patterns of drug-taking behavior among the subjects in our study. To the extent that medication scheduling is a controllable factor, our report provides an insight into specific patterns of behavior that may be targets for adherence counseling. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:1763 / 1767
页数:5
相关论文
共 19 条
[1]   MEASUREMENT IN MEDICINE - THE ANALYSIS OF METHOD COMPARISON STUDIES [J].
ALTMAN, DG ;
BLAND, JM .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 1983, 32 (03) :307-317
[2]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[3]  
Bangsberg D.R., 2001, AIDS Behav, V5, P275, DOI [10.1023/A:1011396711486, DOI 10.1023/A:1011396711486]
[4]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[5]   Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults [J].
Bartlett, JA ;
DeMasi, R ;
Quinn, J ;
Moxham, C ;
Rousseau, F .
AIDS, 2001, 15 (11) :1369-1377
[6]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[7]   Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease [J].
Eldred, LJ ;
Wu, AW ;
Chaisson, RE ;
Moore, RD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (02) :117-125
[8]   A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women [J].
Howard, AA ;
Arnsten, JH ;
Li, YT ;
Vlahov, D ;
Rich, JD ;
Schuman, P ;
Stone, VE ;
Smith, DK ;
Schoenbaum, EE .
AIDS, 2002, 16 (16) :2175-2182
[9]  
Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI [10.1097/01.QAI.0000014768.35851.DB, 10.1097/00126334-200207010-00009]
[10]   Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial [J].
Kastrissios, H ;
Suárez, JR ;
Katzenstein, D ;
Girard, P ;
Sheiner, LB ;
Blaschke, TF .
AIDS, 1998, 12 (17) :2295-2303